suPAR na avaliação do prognóstico após permanência na unidade de terapia intensiva

Detalhes bibliográficos
Autor(a) principal: Silvestre, Joana
Data de Publicação: 2018
Outros Autores: Coelho, Luis, Pereira, João Gonçalves, Mendes, Vitor, Tapadinhas, Camila, Povoa, Pedro
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.5935/0103-507X.20180062
Resumo: OBJECTIVE: To determine the performance of soluble urokinase-type plasminogen activator receptor upon intensive care unit discharge to predict post intensive care unit mortality. METHODS: A prospective observational cohort study was conducted during a 24-month period in an 8-bed polyvalent intensive care unit. APACHE II, SOFA, C-reactive protein, white cell count and soluble urokinase-type plasminogen activator receptor on the day of intensive care unit discharge were collected from patients who survived intensive care unit admission. RESULTS: Two hundred and two patients were included in this study, 29 patients (18.6%) of whom died after intensive care unit discharge. Nonsurvivors were older and more seriously ill upon intensive care unit admission with higher severity scores, and nonsurvivors required extended use of vasopressors than did survivors. The area under the receiver operating characteristics curves of SOFA, APACHE II, C-reactive protein, white cell count, and soluble urokinase-type plasminogen activator receptor at intensive care unit discharge as prognostic markers of hospital death were 0.78 (95%CI 0.70 - 0.86); 0.70 (95%CI 0.61 - 0.79); 0.54 (95%CI 0.42 - 0.65); 0.48 (95%CI 0.36 - 0.58); and 0.68 (95%CI 0.58 - 0.78), respectively. SOFA was independently associated with a higher risk of in-hospital mortality (OR 1.673; 95%CI 1.252 - 2.234), 28-day mortality (OR 1.861; 95%CI 1.856 - 2.555) and 90-day mortality (OR 1.584; 95%CI 1.241 - 2.022). CONCLUSION: At intensive care unit discharge, soluble urokinase-type plasminogen activator receptor is a poor predictor of post intensive care unit prognosis.
id RCAP_6ad7f20e71b13364ca4ed805d5033819
oai_identifier_str oai:run.unl.pt:10362/59720
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling suPAR na avaliação do prognóstico após permanência na unidade de terapia intensivasuPAR in the assessment of post intensive care unit prognosisa pilot studyum estudo pilotoBiomarkersC-reactive proteinPrognosisReceptorsurokinase plasminogen activatorCritical Care and Intensive Care MedicineOBJECTIVE: To determine the performance of soluble urokinase-type plasminogen activator receptor upon intensive care unit discharge to predict post intensive care unit mortality. METHODS: A prospective observational cohort study was conducted during a 24-month period in an 8-bed polyvalent intensive care unit. APACHE II, SOFA, C-reactive protein, white cell count and soluble urokinase-type plasminogen activator receptor on the day of intensive care unit discharge were collected from patients who survived intensive care unit admission. RESULTS: Two hundred and two patients were included in this study, 29 patients (18.6%) of whom died after intensive care unit discharge. Nonsurvivors were older and more seriously ill upon intensive care unit admission with higher severity scores, and nonsurvivors required extended use of vasopressors than did survivors. The area under the receiver operating characteristics curves of SOFA, APACHE II, C-reactive protein, white cell count, and soluble urokinase-type plasminogen activator receptor at intensive care unit discharge as prognostic markers of hospital death were 0.78 (95%CI 0.70 - 0.86); 0.70 (95%CI 0.61 - 0.79); 0.54 (95%CI 0.42 - 0.65); 0.48 (95%CI 0.36 - 0.58); and 0.68 (95%CI 0.58 - 0.78), respectively. SOFA was independently associated with a higher risk of in-hospital mortality (OR 1.673; 95%CI 1.252 - 2.234), 28-day mortality (OR 1.861; 95%CI 1.856 - 2.555) and 90-day mortality (OR 1.584; 95%CI 1.241 - 2.022). CONCLUSION: At intensive care unit discharge, soluble urokinase-type plasminogen activator receptor is a poor predictor of post intensive care unit prognosis.Centro de Estudos de Doenças Crónicas (CEDOC)NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNSilvestre, JoanaCoelho, LuisPereira, João GonçalvesMendes, VitorTapadinhas, CamilaPovoa, Pedro2019-02-05T23:43:48Z2018-10-012018-10-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article7application/pdfhttps://doi.org/10.5935/0103-507X.20180062por0103-507XPURE: 11448071http://www.scopus.com/inward/record.url?scp=85060393252&partnerID=8YFLogxKhttps://doi.org/10.5935/0103-507X.20180062info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:28:41Zoai:run.unl.pt:10362/59720Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:33:26.248530Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv suPAR na avaliação do prognóstico após permanência na unidade de terapia intensiva
suPAR in the assessment of post intensive care unit prognosisa pilot study
um estudo piloto
title suPAR na avaliação do prognóstico após permanência na unidade de terapia intensiva
spellingShingle suPAR na avaliação do prognóstico após permanência na unidade de terapia intensiva
Silvestre, Joana
Biomarkers
C-reactive protein
Prognosis
Receptors
urokinase plasminogen activator
Critical Care and Intensive Care Medicine
title_short suPAR na avaliação do prognóstico após permanência na unidade de terapia intensiva
title_full suPAR na avaliação do prognóstico após permanência na unidade de terapia intensiva
title_fullStr suPAR na avaliação do prognóstico após permanência na unidade de terapia intensiva
title_full_unstemmed suPAR na avaliação do prognóstico após permanência na unidade de terapia intensiva
title_sort suPAR na avaliação do prognóstico após permanência na unidade de terapia intensiva
author Silvestre, Joana
author_facet Silvestre, Joana
Coelho, Luis
Pereira, João Gonçalves
Mendes, Vitor
Tapadinhas, Camila
Povoa, Pedro
author_role author
author2 Coelho, Luis
Pereira, João Gonçalves
Mendes, Vitor
Tapadinhas, Camila
Povoa, Pedro
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Centro de Estudos de Doenças Crónicas (CEDOC)
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
RUN
dc.contributor.author.fl_str_mv Silvestre, Joana
Coelho, Luis
Pereira, João Gonçalves
Mendes, Vitor
Tapadinhas, Camila
Povoa, Pedro
dc.subject.por.fl_str_mv Biomarkers
C-reactive protein
Prognosis
Receptors
urokinase plasminogen activator
Critical Care and Intensive Care Medicine
topic Biomarkers
C-reactive protein
Prognosis
Receptors
urokinase plasminogen activator
Critical Care and Intensive Care Medicine
description OBJECTIVE: To determine the performance of soluble urokinase-type plasminogen activator receptor upon intensive care unit discharge to predict post intensive care unit mortality. METHODS: A prospective observational cohort study was conducted during a 24-month period in an 8-bed polyvalent intensive care unit. APACHE II, SOFA, C-reactive protein, white cell count and soluble urokinase-type plasminogen activator receptor on the day of intensive care unit discharge were collected from patients who survived intensive care unit admission. RESULTS: Two hundred and two patients were included in this study, 29 patients (18.6%) of whom died after intensive care unit discharge. Nonsurvivors were older and more seriously ill upon intensive care unit admission with higher severity scores, and nonsurvivors required extended use of vasopressors than did survivors. The area under the receiver operating characteristics curves of SOFA, APACHE II, C-reactive protein, white cell count, and soluble urokinase-type plasminogen activator receptor at intensive care unit discharge as prognostic markers of hospital death were 0.78 (95%CI 0.70 - 0.86); 0.70 (95%CI 0.61 - 0.79); 0.54 (95%CI 0.42 - 0.65); 0.48 (95%CI 0.36 - 0.58); and 0.68 (95%CI 0.58 - 0.78), respectively. SOFA was independently associated with a higher risk of in-hospital mortality (OR 1.673; 95%CI 1.252 - 2.234), 28-day mortality (OR 1.861; 95%CI 1.856 - 2.555) and 90-day mortality (OR 1.584; 95%CI 1.241 - 2.022). CONCLUSION: At intensive care unit discharge, soluble urokinase-type plasminogen activator receptor is a poor predictor of post intensive care unit prognosis.
publishDate 2018
dc.date.none.fl_str_mv 2018-10-01
2018-10-01T00:00:00Z
2019-02-05T23:43:48Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.5935/0103-507X.20180062
url https://doi.org/10.5935/0103-507X.20180062
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv 0103-507X
PURE: 11448071
http://www.scopus.com/inward/record.url?scp=85060393252&partnerID=8YFLogxK
https://doi.org/10.5935/0103-507X.20180062
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 7
application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137955869097984